We are live on
!
Find out more
A
AustralianSuper Portfolio holdings
AUM
$19.2B
1-Year Est. Return
31.95%
This Fund
S&P 500
This Quarter
Est. Return
+4.32%
1 Year Est. Return
+31.95%
3 Year Est. Return
+101.58%
5 Year Est. Return
+115.19%
10 Year Est. Return
–
AUM
$2.21B
AUM Growth
+$913M
(+70%)
Cap. Flow
+$874M
Cap. Flow
% of AUM
39.47%
Top 10 Holdings %
Top 10 Hldgs %
45.87%
Holding
53
New
25
Increased
9
Reduced
8
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$91.1M |
| 2 |
Texas Instruments
TXN
|
+$81.4M |
| 3 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$80M |
| 4 |
Meta Platforms (Facebook)
META
|
+$79.1M |
| 5 |
UnitedHealth
UNH
|
+$78.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$45.6M |
| 2 |
Pfizer
PFE
|
+$24.3M |
| 3 |
K
Kellanova
K
|
+$23.4M |
| 4 |
Philip Morris
PM
|
+$3.14M |
| 5 |
Accenture
ACN
|
+$2.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.44% |
| 2 | Technology | 14.34% |
| 3 | Communication Services | 13.74% |
| 4 | Consumer Discretionary | 13.49% |
| 5 | Financials | 13.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
IQVIA
IQV
$34.4B
| $0 | ﹤0.01% |
1
| – | – |
|
|
K
52
DELISTED
Kellanova
K
| – | – |
-359,544
| Closed | -$23.4M |
|
|
53
Pfizer
PFE
$143B
| – | – |
-761,304
| Closed | -$24.3M |
|
Similar funds
CS
LF
PCM
MGP
SOMRS
BPA
NAM
AustralianSuper's Q3 2017 Portfolio in Review
As of Q3 2017, AustralianSuper held 53 positions worth $2.21B, up 70% from $1.3B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
AustralianSuper deployed $874M of net new capital in Q3 2017, opening 25 new positions and adding to 9 existing holdings. Its largest new stake was Chevron: 834,700 shares worth $98.1M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 14% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Visa, an estimated $45.6M trimmed.
- AustralianSuper's largest Q3 2017 buy was Chevron: 834,700 shares worth $98.1M.
- AustralianSuper added most to Thermo Fisher Scientific in Q3 2017, an estimated $53M increase.
- AustralianSuper's biggest Q3 2017 reduction was Visa, cutting an estimated $45.6M.
- AustralianSuper fully exited Pfizer in Q3 2017, selling an estimated $24.3M.
- AustralianSuper's ten largest holdings make up 46% of its $2.21B portfolio in Q3 2017.
- AustralianSuper opened 25 new positions and closed 2 in Q3 2017.
- AustralianSuper's portfolio value rose 70% quarter-over-quarter to $2.21B.
Based on AustralianSuper's 13F filing for Q3 2017, filed 15 Dec 2017.